NEW YORK, June 21 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as the introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems which will utilize amplification methods.
In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new DNA probe and biochip technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next ten years.
This comprehensive worldwide study is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the molecular diagnostics market during the next decade. The study explores business and technological trends in major markets; provides 5-and 10-year test volume and sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next ten years.
Contains 1,050 pages and 96 tables
Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.
WORLDWIDE MARKET OVERVIEW, 2008-2017
The study will provide a concise strategic overview of the worldwide electronics market, including five-year forecasts for major geographic regions, market segments and product categories.
In addition, a review of the major U.S. and international economic, technological, demographic, social and regulatory trends with potentially significant impact on the electronics market during the next five years will be presented.
COMPANY STRATEGIC ASSESSMENTS
The following companies have been selected as the TOP 10 suppliers with the highest worldwide sales of electronic products: For each of the Top 10 companies, the report will provide an approximately 65-page strategic analysis, including the following information:
SECTION I: EXECUTIVE SUMMARY
A 3-5 page synopsis of key sections.
SECTION II: BUSINESS ORGANIZATION
History of the company's electronics business evolution, important to the understanding of the corporate culture, management mentality and strategies.
Most recent acquisitions, divestitures and significant organizational changes.
Current organizational structure.
SECTION III: SENIOR MANAGEMENT
Background of senior managers.
SECTION IV: FACILITIES AND EMPLOYEES
Major administrative, manufacturing and R&D facilities in the U.S. and abroad.
New plants under construction.
U.S. and international work force.
SECTION V: TECHNOLOGICAL KNOW-HOW
Internally developed and acquired technologies, processes and related capabilities.
Proprietary know-how and patent litigations.
SECTION VI: PRODUCT PORTFOLIO ANALYSIS
Review of major product lines.
Most recent new product introductions and line extensions.
SECTION VII: MARKETING TACTICS
Sales force in the U.S. and international markets.
SECTION VIII: FINANCIAL ANALYSIS
The U.S. and international sales and operating profit estimates by division, geographic region, market segment and product line.
Five-year sales and operating profit performance.
SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
Estimated R&D budget.
Research facilities and staff.
New technologies, products and product line extensions in development.
SECTION X: COLLABORATIVE ARRANGEMENTS
Major joint venture, product development and marketing partners.
Terms of collaborative agreements and specific products involved.
SECTION XI: STRATEGIC DIRECTION
Strengths and weaknesses.
Specific business, new product development and marketing objectives and strategies.
Anticipated acquisitions, joint ventures and divestitures.
In this section of the report, the Top 10 companies will be ranked according to the following criteria:
Worldwide sales of electronic products.
Sales estimated in North America, Europe, Japan and other regions.
Sales estimates by major product category.
Operating profit, and margins.
R&D expenditures, and others.
To order this report:
Blood Supply, Tissue Banking and Transplantation Industry: Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
Intl: +1 805-652-2626